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INTRODUCTION
Secretory immunoglobulin A (sIgA) is the dominantimmunoglobulin in the gut mucosal surfacegiving the mucosa specialized innate and adaptive defense against ingested pathogens and their toxins [1] [2] [3] .sIgAis a protein complex consisting of two identical IgA monomers, joined together by a 16-kDa joint chain (Jchain) with one potential N-glycosylation site, and the secretory component (SC) with seven potential N-glycosylation sites [4] [5] [6] . The four polypeptide chains of sIgAare produced by two distinct cell types 6 .Plasma cells close to the epithelium produce dimeric IgA with an attached J chain, while epithelial cells express the polymeric immunoglobulin receptor (pIgR) that binds to dimeric IgA. Notably, the SC is derived from the pIgR after cleavage of the trans-membrane tail on the surface of epithelial cells 7 .
Glycosylation is one of the most common but also the most structurally complicated posttranslational modification(PTM) of proteins. Approximately 70% of human proteins are predicted to be glycosylated 8, 9 .sIgA is heavily glycosylated with both N-and/or O-linked oligosaccharides 10 ,which vary according to the isotype and allotype of the immunoglobulin.Its oligosaccharidesare attributedsignificant roles in immune protection, cell signaling, cell-cell recognition, microbial adhesion and invasion [11] [12] [13] .sIgA is one of the major antibodies produced in human milk and is essential for the passive immunity of infants against infection [14] [15] [16] . Specific binding between sialylated glycans of sIgA and pathogens such as S-firmbriated Escherichia coliprotectsnewborns from sepsis and meningitis due to infection 17 .The large diversity of Nglycan structures particularly on the SC providesmany glycan epitopes that are potent decoys for lectins on bacterial surfaces thereby inhibiting infection by attachment with epithelial surfaces [18] [19] [20] . sIgA also carries galactose-terminating glycans that protect against toxins including ricin, a particularly toxic galactose-specific lectin 21 .
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Despite numerous studies establishing theeffective protection provided by sIgA,the glycan heterogeneity and glycosite occupancy of this highly glycosylated proteinremains incomplete.There have been studies showing the glycosylation of IgA in serum 22, 23 , however milk is unique in that the protein also contains a highly glycosylated secretory component 10 . The first comprehensive attempt to characterize the glycosylation of sIgA from a commercial samplewas reported by Royle et al. 4 , whereby polypeptide components were separated using gelelectrophoresis. Glycans were released for the respective gel spots corresponding to different polypeptides and characterized by mass spectrometry. The nature of the method yielded no sitespecific information. Furthermore, the glycoforms spread the location of the glycoprotein on the gel, so releasing glycans from the largely-spread gel spot may not necessarily represent the majority of the glycoforms 24 .Site-specific N-glycan analysis of sIgA was first performed by
Deshpande et al.using in-gel trypsin digestion of a commercial sample 25 . The results provided the characterization of several sites with the associated glycan heterogeneity. However, trypsin often produces large peptides, and in this case it could not resolve the glycosylation of 83 Asn and 90 Asn on the secretory component. Additionally, missed cleavages are common occurrences particularly if the tryptic sites are near sites of glycosylation [26] [27] [28] .For these reasons, employing only tryptic digestion will often yield incomplete glycan information.
A more complicated aspect is the O-glycosylation analysis of sIgA. The IgA1 hinge region contains up to nine potential O-glycosylation sites clustering in a 19 amino acidpeptide sequence 29 .A variety of MS analytical approaches have been used to characterize the glycan heterogeneity present in this portion of the immunoglobulin with only moderate success [30] [31] [32] [33] . Additionally, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 6 ECD/ETD 29, 32, 33 . However in these studies sialic acid was removed enzymatically in order to simplify the glycopeptide heterogeneity.
In this paper, we present an extensive and comprehensive glycan analysis of sIgA fromcommercial pooled human colostrum and isolated from milk colostrum collected from three healthy women. This laboratory hasdeveloped methods for site-specific analysis using combinations of specific and non-specific proteolysis [34] [35] [36] [37] [38] [39] [40] . The methodincludes an automated annotation software (Glycopeptide Finder) to analyze data from a nanoflow liquid chromatography coupled with quadrupole time-of-flight analyzer (nanoLC-Q-TOF). This analysis yielded both N-and O-glycosylation.Glycopeptide assignmentswere based on a combination of accurate mass, retention time analysis and tandem MS yielding glycopeptides withscalable lengths but including both non-specific and specific cleavages.
Materials and Methods

Chemicals and Materials
SSL7/Agarose and phosphate-buffered saline (PBS), and TRIzolwere purchased from Invitrogen (San Diego, CA). Pronase E, cyanogen bromide (CNBr) activated sepharose 4B (S4B) beads, and pooled human colostrum IgA were purchased from Sigma-Aldrich (St. Louis, MO).
PNGase F was purchased from New England Biolab (Ipswich, MA). Sequencing grade modified trypsin and proteoMAX solutionwere purchased from Promega (Madison, WI). Dialysis tubing (10MWCO) were purchased from Spectrum Lab (Rancho Dominguez, CA). Ammonium acetate and acetic acid were of analytical grade from Merck (Darmstadt, Germany). Graphitized carbon cartridges were purchased from Grace Davison Discovery Sciences (Deerfield, IL). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 7
Human Colostrum Samples
Colostrum sampleswere collected from three healthy donors enrolled in the UC Davis Lactation Study who gave birth to term infants (> 38 weeks). Colostrum samples were manually collected on day 3-6 postpartum from one breast and transferred into polypropylene Falcon tubes, and frozen immediately in their kitchen freezers (-20 ºC) until weekly sample pick up by the study staff. Samples were transported to the lab on dry ice and stored in -80 ºC until processing.
The University of California Davis Institutional Review Board approved all aspects of the study and informed consent was obtained from all subjects. This trial was registered on clinicaltrials.gov (ID: NCT01817127).
Secretory Immunoglobulin A Extraction
sIgA from donor colostrum was extracted using Staphylococcal Superantigen-Like Protein 7
(SSL 7)/agarose 41 .Briefly, whole human colostrum samples (0.5 mL) were centrifuged at 4000 xg, for 30 minutes at 4°C. A CaCl 2 solution (pH 4.6) was added to the lower layer after the removal of top layer fat and lipids to a final concentration of 60 mM. The mixture was incubated 1 hour at room temperature (~25˚C), and further centrifuged at 6750 xg for 30 minutes. The top layer was extracted as whey proteins. Theempty column was packed with 1ml of SSL 7/agorose resin and equilibrated with 1X phosphate buffer saline (running buffer). The whey fractions were loaded onto the columns and the flow-through was collected and reloaded onto the column three times. Upon washing with 10 mL of the running buffer, sIgA bound to SSL 7 was eluted with 5 mLof 0.1 M glycine (pH 2-3) followed by the pH adjustment of the eluate to pH 7.5 by adding a neutralization buffer (1M Tris pH 8). Fractions were collected, dialyzed using a dialysis membrane with a molecular weight cut-off of 10,000 against nano-pure water, concentrated and stored at -20°C. Protein concentration was determined using the Bradford assay and 5 µl aliquots 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   8 were assayed by SDS-PAGE to confirm protein purity.A 5-µL sample was mixed with 5 µL of laemli buffer, 1 µL of 550 mM dithiothreitol (DTT) at 60 °C for 1 hour prior to incubating with 2 µL of 450 mM iodoacetamide (IAA) for 30 min in the dark. The SDS-PAGE was performed at 140 V for 1 hr, followed by staining with coomasie blue for 1 hr. The gel was then unstained with water overnight.
Trypsin Digestion
A 100µL aliquot of 50 mM NH 4 HCO 3 buffer was added to 10 µg isolated sIgA as described 
LC/MS analysisof glycopeptides
A nano-HPLC-Chip Q-TOF instrument using the Agilent 1200 series microwell-plate autosampler (maintained at 6 ºC by the thermostat), capillary pump, nano pump, HPLC-Chip 
Data Processing
11
The MS/MS data of the tryptic peptides were analyzed using X! Tandem (www.thegpm.org). X! Tandem was set up to search the Swissprot human complete proteome database. X! Tandem was searched with a fragment ion mass tolerance of 80 ppm and a parent ion tolerance of 100 ppm.
Iodoacetamide derivative of cysteine was specified in X! Tandem as a fixed modification.
Deamidation of asparagine and glutamine, oxidation of methionine and tryptophan were specified in X! Tandem as variable modifications.
Data analyses for N-glycopeptides were performed with the MassHunter Qualitative Analysis software ver. B.03.01 (Agilent Technologies, Inc., Santa Clara, CA). Deconvolution was performed in the software with the grouping peak spacing tolerant of 0.0025 m/z plus 7 ppm and isotope mode was set for peptides. The mass list of the glycopeptide precursor ions and the associated tandem spectra were analyzed via an in-house software (Glycopeptide Finder) 39 set to a 5% false-discovery rate. All N-glycopeptide assignments were made based on the mass of each potential glycopeptide, the amino acid sequence(s) of the protein(s), and a specific tolerance level (< 20 ppm). The presence of carbohydrate-specific oxonium fragment ions was used as diagnostic ions to sort the product tandem spectra. 
Results and Discussion
Glycan-heterogeneity of sIgA from Human Colostrum
Colostrum sIgA was extracted from three individual donors.Isolation of sIgA was performed as outlined in the methods section. The purity of sIgA was assessed by SDS-PAGE with four main bands corresponding to the SC, H chain and light chain of IgA, and J chain as shown in Figure S1 . Standard proteomic analysis was performed on the isolated sIgA to further confirm the purity of the protein. The resultsare listed in Table S1 and indicate that the isolated sIgA is relatively pure with only very minor protein contaminants.
The extracted compound chromatograms (ECCs) produced by the molecular feature extractor (MFE)demonstrate similar glycopeptide profiles as well as abundances for the three colostrum sIgA samples ( Figure S2) . A list of glycopeptides from the pronase-digested sIgA isolated from one representative colostrum sample is shown in Table 1 . The ECCs produced by the MFE yielded intensities that were used for obtaining relative abundances. Abundances for all peptides and glycoforms representing a specific site were added 37 .
The elution order of glycopeptides on PGC follows loosely a set of empirical rules 43, 44 .
Smaller peptides elute before larger ones with the same glycoforms. For example, the most (peaks in pink) were among the less intense peaks and originated from the single site on the J chain. All the glycopeptides from the J chain were observed to contain at least one Neu5Ac. The glycopeptides eluting between 7 min to 29 min illustrate the large complexity and the dynamic range of the glycosylation (Figures 1B and 1C) .
To obtain structural information from the peaks in Figure 1 , tandem MS spectra were performed (shown in Figure S3 ). We have previously reported characteristic fragmentation of glycopeptides. Glycan fragmentation yielding B-type ions is commonly observed in the collision induced dissociation (CID) spectra of glycopeptides 45 .A typical tandem MS spectrum is shown 6 ). In this study, higher abundances of tetraantennary structures were detected from sIgA compared with earlier work 4 . Figure 2C depicts the CID data with the loss of the two Neu5Ac (291 Da) residues to yield the extent of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 peptide, LTNFPE 90 NGTFVVNIAQLSQ associated with the trimannosyl core arepresent in both spectra indicating the same peptide were present in the two glycopeptides.
Glycan-heterogeneity of pooled human colostrumsIgA
The same experimentswere performed on pooled human colostrum sIgA obtained commercially.A list of glycopeptides from the pronase-digested sIgA is shown in Table S2 .
Amuch lower diversity of peptides and glycan structures were observed with the commercial pooled sIgA as compared to the isolated sIgA from individual donors. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 deconvoluted MS/MS spectra of the glycopeptides from J chain and SC, respectively. The fragment denoted as peptide+HexNAc was observed and highly informative for identifying the two glycopeptides. Figure S6A shows the fragmentation of one of the most abundant Figure S6B and S6C, which provides the glycan heterogeneity of this site. The fact that glycan heterogeneity was observed at this site with various peptide backbone as shown in Table 1 is a confirmation that this site is glycosylated. There are also reports in literature that support glycosylation on this site. In a report by Picariello et al., they found tryptic peptides from this site is potentially modified and glycosylated 46 .A 1Da mass shift from the peptide after PNGase F release is indicative of a putative N-glycan site.
Assignment of the glycopeptide structures using the software GP Finder was performed with 95% confidence based on decoy data. Some assignments were complicated by the large number 
Semi-quantitativeSite-specific Glycosylation
A summary of detailed and comprehensive glycan site heterogeneity of the sIgA isolated from a single human colostrum sample is depicted in Figure 4A -C. The result of the pooled commercial sample is shown in Figure 4D -F. The sIgA glycopeptide profiles were found to be similar between the fresh human colostrum samples from three donors. However, these sampleswere more highly glycosylated thanthe pooled commercial sample. For example, commercial sIgA was not found glycosylated in 186 N of the SC while fresh colostrum was glycosylated. A greater site-heterogeneity was observed with most of the sites in the fresh Quantitative information was obtained based on the abundances of the glycopeptides. Two types of quantitative information are provided in the figures. The small circular symbol under the glycan structure designates the abundance of that glycan relative to all the glycans at that glycosite. The circular symbol under the amino acid represents the occupancy of the site. To obtain these values, the MS abundances for all glycoforms associated with a site were added.
The abundances were then combined for each glycoform and normalized to the total site abundance for the relative glycan abundance at each site. The sum for each site represents the occupancy while the sum for each glycan represents the relative abundance of the glycoform.
The occupancy is further normalized to the most occupied site (100%). Quantitation of glycan site occupancy remains a difficult task. We propose a semi-quantitative method using ion abundances but, for the moment, neglecting issues such as differences in ionization efficiency of different peptides and different glycoforms as well as the dispersion of ion abundances across different peptides due to the nature of the nonspecific proteases. Nonetheless, a previous study by Hua et al. reported the quantitative accuracy and reproducibility of non-specific glycosylation analysis and revealed the efficiency of this method 47 . In this way, we find that the most abundant site is 92 Asn of the IgA2 in the protein complex. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 structures were observed. Glycosylation was found to be most abundant at 90 Asn among the sevensites on SC, followed by 83 Asn and 135 Asn.
The characterization of the site heterogeneity on the Jchain is summarized inFigure 4B.
Krugman et al. 48 previouslyreported that the substitution of the Asn with Ala in J chain prevents
IgA dimer formation, indicating the significance of glycosylation to the tertiary structure. Also, the glycans associated with J chain are essential for binding and trans-locating pIgRacrossepithelial cells 49 .However, the results obtained here show a single site ( 71 Asn) with less than 20% occupancy corresponding to mainly sialylated complex type glycans. The results are consistent with previous work but it calls to question contributionof this glycosite given the relatively low occupancy.
The H chain of IgA is significantly more glycosylated than the J chain and the SC. Figure 4C details the abundances of site-specific IgA1 H chain and IgA2 H chain glycans. as discussed previously from the MS/MS data, mainly due to the observation of the loss of fucose to yield an informativeY 1 ion.
Overall, from the colostrum of individual donors,sialylated glycans were found to be the most abundant (82%), from which mono-sialylation (35%) and bi-sialylation (47%) were both present.
Fucosylation (36%) were observed mostly as core fucosylation. Figure 4D-4F) .
O-glycosylation Analysis
We have previously determined N-and O-glycosylation simultaneously for other glycoproteins, 24, 36, 37, 47 however the same comprehensive analysis described above failed to The enriched O-glycopeptide fraction was analyzed in both MS and MS/MS mode.
Aglycopeptide library was employed toidentify the glycopeptidesusing accurate mass andthe theoretical isotopic distribution. This approach revealed 54 compounds compiled in Table 2 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 However,O-glycopeptide assignments were confirmedbycomparingthe elution order. The elution order follows a certain pattern as illustrated in Figure 6 for the O-glycopeptideseries containing five N-acetylgalactosamine, three galactose and different number of sialic acid residues.
In every case, the addition of sialic acid residues increases the retention time of the corresponding O-glycopeptides( Figure S7) .Similarly, the elution time order can be comparedwith the number of hexoses orhexosamines residues. The addition of these monosaccharides decreased gradually the retention time ( Figure S8) . The combined comparison of the elution orders confirmed the compound assignments. Isomeric o-glycopeptides were found for 5 different compositions when examining the extracted compounds chromatograms ( Figure   S7 ).The results are in agreement with those published previously 25 .
CONCLUSION
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